# EDGAR Filing Document

**Accession Number:** 0001822995
**File Stem:** 0001096906-26-000522
**Filing Date:** 2026-4
**Character Count:** 5676
**Document Hash:** 07a9b570b4e7b537a11e617d3d0e2c8c
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001096906-26-000522.hdr.sgml**: 20260410

**ACCESSION NUMBER**: 0001096906-26-000522

**CONFORMED SUBMISSION TYPE**: 1-U

**PUBLIC DOCUMENT COUNT**: 5

**CONFORMED PERIOD OF REPORT**: 20260316

**ITEM INFORMATION**: Changes in Issuer's Certifying Accountant

**FILED AS OF DATE**: 20260410

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** GATC HEALTH CORP
- **CENTRAL INDEX KEY:** 0001822995
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-HEALTH SERVICES [8000]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 851074632
- **STATE OF INCORPORATION:** WY
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 1-U
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 24R-00529
- **FILM NUMBER:** 26854112

**BUSINESS ADDRESS:**
- **STREET 1:** 2030 MAIN STREET
- **STREET 2:** SUITE 660
- **CITY:** IRVINE
- **STATE:** CA
- **ZIP:** 92614
- **BUSINESS PHONE:** 9492608070

**MAIL ADDRESS:**
- **STREET 1:** 2030 MAIN STREET
- **STREET 2:** SUITE 660
- **CITY:** IRVINE
- **STATE:** CA
- **ZIP:** 92614

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

**FORM 1-U**

**CURRENT REPORT PURSUANT TO REGULATION A**

Date of report (Date of earliest event reported) March 16, 2026

![](gatc1u_1.jpg)

**GATC HEALTH CORP**

(Exact name of issuer as specified in its charter)

Wyoming 85-1074632 <br> (State or other Jurisdiction of I.R.S. Employer- <br> Incorporation or Organization Identification No.)

2030 Main Street, Suite 660, Irvine CA 92614

(Address of Principal Executive Offices and zip code)

(833) 333-4282

(Issuer's Telephone Number, including Area Code)

Title of each class of securities issued pursuant to Regulation A: Common Stock, par value $.0001

------

**Item 4. Change in Issuer's Certifying Accountant**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(a)** **Dismissal of Independent Registered Public Accounting Firm**

On March 16, 2026, we dismissed Haskell &White LLP ("Haskell & White") as our independent registered public accounting firm, effective immediately. During the years ended December 31, 2024 and 2023 and through March 16, 2026, there were no disagreements with Haskell & White, or any reportable events with respect thereto, on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreements, if not resolved to the satisfaction of the former accountant, would have caused it to make reference to the subject matter of the disagreement(s) in connection with its report. The report of Haskell & White on the consolidated financial statements of GATC Health Corp (the "Company") as of and for each of the years ended December 31, 2024 and 2023 included an explanatory paragraph expressing substantial doubt regarding the Company's ability to continue as a going concern. In connection with their audits, Haskell & White advised the Company of existing material weaknesses in its internal control over financial reporting. The dismissal of Haskell and White was approved by the Audit Committee of the Board of Directors.

We have discussed the above with Haskell & White and have authorized Haskell & White to respond fully to the inquiries of any successor accountant. We have provided Haskell & White with a copy of this disclosure, and a letter from Haskell & White to the Securities and Exchange Commission is filed with this Report stating whether it agrees with the above statements.

**(b) Engagement of New Independent Registered Public Accounting Firm**

On April 3, 2026, the Audit Committee approved the engagement of Kreit & Chiu CPA LLP ("KC") as the Company's independent registered public accounting firm for the fiscal year ended December 31, 2025.

During the Company's two most recent fiscal years ended December 31, 2025 and 2024 and the subsequent interim period through April 3, 2026, neither the Company nor anyone acting on its behalf consulted KC regarding: (i) the application of accounting principles to a specified transaction, either completed or proposed, or the type of audit opinion that might be rendered on the Company's financial statements, and no written report or oral advice was provided to the Company by KC that was an important factor considered by the Company in reaching a decision as to any accounting, auditing, or financial reporting issue; or (ii) any matter that was either the subject of a disagreement, as that term is defined in Item 304(a)(1)(iv) of Regulation S-K and the related instructions thereto, or a reportable event, as described in Item 304(a)(1)(v) of Regulation S-K.

------

**Exhibits**

9.4. [Letter from Haskell & White LLP.](gatc_ex9z4.htm)

Pursuant to the requirements of Regulation A, the issuer has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

**GATC HEALTH CORP**

---

| |
|:---|
| */s/ Gerald DeCiccio* |
| Chief Financial Officer<br> April 10, 2026 |

---

------

## Exhibit 9.4

![](gatcex9z4_1.jpg)

April 10, 2026

**United States Securities and Exchange Commission**

100 F Street, N.E.

Washington, DC 20549

Ladies and Gentlemen:

We have read Item 4 of Form 1-U dated March 16, 2026 of GATC Health Corp (the "Company") and agree with the statements relating only to Haskell & White LLP contained therein. We have no basis to agree or disagree with other statements of the Company contained therein.

We hereby consent to the filing of this letter as an exhibit to the foregoing report on Form 1-U.

---

| |
|:---|
| /s/ Haskell & White LLP |
| HASKELL & WHITE LLP |

---

![image3.jpeg](gatcex9z4_2.jpg)